Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Diabetologist
FCPS (Medicine), FCPS (Endocrinology), FRCP (UK), MRCP (UK), M.B.B.S.
Diabetologist
FCPS (Medicine), FCPS (Endocrinology), FRCP (UK), MRCP (UK), M.B.B.S.
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Gastroenterologist
MBBS, FCPS(Gastroenterology), FCPS(Medicine)
Gastroenterologist
MBBS, FCPS(Gastroenterology), FCPS(Medicine)
Consultant Physician
M.B.B.S., M.D.
Internal Medicine Specialist
MRCP (UK), FRCP (Glasg.), MBBS
Internal Medicine Specialist
M.B.B.S., Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., Diplomate of American Board (Internal Medicine)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures